Lind Global Fund II LP 13D/13G Filings for Quoin Pharmaceuticals, Ltd. (QNRX)

Lind Global Fund II LP 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
7:23 pm
Unchanged
2024-09-3013GQUOIN PHARMACEUTICALS LTD SPON
QNRX
Lind Global Fund II LP62,500
1.200%
0
(Unchanged)
Filing